MERRIMACK PHARMACEUTICALS INC

The global Novel Drug Delivery Systems In Cancer Therapy market size was valued at 16.95 billion in 2023 and is projected to surpass USD 33.34 billion by 2033 with a CAGR of 7% from 2024 to 2033. Market growth is attributed to the adoption of minimally invasive procedures, personalized treatment, precision medicine, and targeted therapies. Technological advancements, increased funding, and rising awareness contribute to market expansion.

Ipsen employee Dishant Gupta charged with insider trading after allegedly profiting from stock transactions based on non-public knowledge of the company's $247 million buyout of Epizyme. Gupta, who agreed to plead guilty, faces a monetary penalty and is barred from serving as an executive or director of any publicly traded company. Ipsen's oncology portfolio expansion includes acquisitions like Epizyme's Tazverik and Merrimack Pharmaceuticals' Onivyde, along with deals for cancer drug development programs.

OTR Leasing helps CDL-A drivers affordably realize truck ownership dreams with flexible, affordable lease terms, fast-track approval, ongoing support, and an extensive inventory of reliable trucks. They offer tools for both new owner-operators and fleet expansion, empowering drivers to manage their businesses without carrier restrictions.